- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.
SPARC's Board approved the financial results for the quarter, with a consolidated loss of ₹20.78 Cr. The board also approved reclassifying certain promoter group individuals. During the quarter, 3.85 Cr warrants were allotted preferentially at ₹155.80 each, and a licensing agreement was terminated, refunding $2M.